UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ES15.04 Engaging Lung Cancer Patients in their Molecular Testing

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S80-S80

Ciupek, A.

2021

Volltextzugriff (PDF)

OA10.05 Patient-Facing Biomarker Testing Reports: Views and Preferences of People with Lung Cancer and Caregivers

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S66-S67

2023

Volltextzugriff (PDF)

MA07.03 Analyzing and Understanding the Unmet Needs of Lung Cancer Patients and Their Loved Ones

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S122

2023

Volltextzugriff (PDF)

MA05.08 LungMATCH - The Impact of Direct to Patient Clinical Trial Navigation on Engagement In the Lung Cancer Trial Process

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S115

2023

Volltextzugriff (PDF)

P2.08-01 Real-world barriers to clinical trial enrollment as reported by U.S. lung cancer patients and community cancer centers

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S136

2022

Volltextzugriff (PDF)

MA22.01 Lung Cancer Patients’ Unique Values and Preferences Lead to Clinical Trial Preferences

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S339-S339

2019

Volltextzugriff (PDF)

OA10.03 How LungMATCH, A Personalized Treatment Navigation and Clinical Trial Matching Service, Affects the Treatment Journey

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S864-S865

2021

Volltextzugriff (PDF)

FP02.03 Factors Associated With Delayed Lung Cancer Diagnosis

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S947-S947

2021

Volltextzugriff (PDF)

MA05.02 Impact of Covid-19 on Lung Cancer Care and Utilization of Patient Support Resources

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S899-S899

2021

Volltextzugriff (PDF)

P41.02 Implementation Barriers In US-based Lung Cancer Screening Programs

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S472-S473

2021

Volltextzugriff (PDF)

MA07.01 No Longer Outliers: Understanding the Needs of Long-Term Lung Cancer Survivors

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S378-S378

2018

Volltextzugriff (PDF)

P1.12-01 Lung Cancer Screening in the COVID-19 Era: Understanding Program-Level Impact

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S110-S111

2022

Volltextzugriff (PDF)

P1.09-01 The Lung Cancer Patient Experience and Care Pathway: A Multi-Country Survey

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S105-S106

2022

Volltextzugriff (PDF)

P1.11-003 A Personalized Navigation Program to Increase Clinical Trial Participation of Lung Cancer Patients

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2027-S2027

2017

Volltextzugriff (PDF)

Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations

Antimicrobial agents and chemotherapy, 2022-05, Vol.66 (5), p.e0172521-e0172521

2022

Volltextzugriff (PDF)

MA07.10 Utilizing a Personalized Navigation Program to Identify Barriers and Increase Clinical Trial Participation Among Lung Cancer Patients

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S380-S381

2018

Volltextzugriff (PDF)

P3.11-04 Trends and Barriers in Lung Cancer Screening Implementation Across the United States

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S960-S960

2018

Volltextzugriff (PDF)

MA07.11 An International Survey Assessing the Unmet Needs of Family Caregivers of People with Lung Cancer: Preliminary Findings

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S125

2023

Volltextzugriff (PDF)

P2.16-23 Rates of Support and Care Offerings Among Patients in an Advocacy Organization Sponsored Lung Cancer Patient Registry

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S874-S875

2019

Volltextzugriff (PDF)

P2.15-13 Implementation of a Democratized Approach to Multi-Omic Molecular Profiling Via the LungMATCH Program

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S822-S822

2018

Volltextzugriff (PDF)

P1.01-036 Identifying and Addressing Gaps in Molecular Testing for Patients with Lung Cancer

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1907-S1907

2017

Volltextzugriff (PDF)

P1.02-03 The Role of Lung Cancer Advocacy Organizations in Biomarker Testing

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S509-S509

2018

Volltextzugriff (PDF)

Tick-borne encephalitis as a notifiable disease--Status quo and the way forward. Report of the 17th annual meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE)

Ticks and tick-borne diseases, 2015-07, Vol.6 (5), p.545-548

Kunze, Ursula

2015

Volltextzugriff (PDF)

Abstract P5-06-08: Role of Androgen Receptor in Metastasis and Hormone Resistance of Estrogen Receptor Positive Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P5-P5-06-08

2010

Volltextzugriff (PDF)

Abstract P5-06-01: MTA2 and AR Overexpression in ER-Negative Breast Cancer Cells: Roles in Invasion and Metastasis

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P5-P5-06-01

2010

Volltextzugriff (PDF)

1 – 25 von 586

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(560)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

ES15.04 Engaging Lung Cancer Patients in their Molecular Testing

OA10.05 Patient-Facing Biomarker Testing Reports: Views and Preferences of People with Lung Cancer and Caregivers

MA07.03 Analyzing and Understanding the Unmet Needs of Lung Cancer Patients and Their Loved Ones

MA05.08 LungMATCH - The Impact of Direct to Patient Clinical Trial Navigation on Engagement In the Lung Cancer Trial Process

P2.08-01 Real-world barriers to clinical trial enrollment as reported by U.S. lung cancer patients and community cancer centers

MA22.01 Lung Cancer Patients’ Unique Values and Preferences Lead to Clinical Trial Preferences

OA10.03 How LungMATCH, A Personalized Treatment Navigation and Clinical Trial Matching Service, Affects the Treatment Journey

FP02.03 Factors Associated With Delayed Lung Cancer Diagnosis

MA05.02 Impact of Covid-19 on Lung Cancer Care and Utilization of Patient Support Resources

P41.02 Implementation Barriers In US-based Lung Cancer Screening Programs

MA07.01 No Longer Outliers: Understanding the Needs of Long-Term Lung Cancer Survivors

P1.12-01 Lung Cancer Screening in the COVID-19 Era: Understanding Program-Level Impact

P1.09-01 The Lung Cancer Patient Experience and Care Pathway: A Multi-Country Survey

P1.11-003 A Personalized Navigation Program to Increase Clinical Trial Participation of Lung Cancer Patients

Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations

MA07.10 Utilizing a Personalized Navigation Program to Identify Barriers and Increase Clinical Trial Participation Among Lung Cancer Patients

P3.11-04 Trends and Barriers in Lung Cancer Screening Implementation Across the United States

MA07.11 An International Survey Assessing the Unmet Needs of Family Caregivers of People with Lung Cancer: Preliminary Findings

P2.16-23 Rates of Support and Care Offerings Among Patients in an Advocacy Organization Sponsored Lung Cancer Patient Registry

P2.15-13 Implementation of a Democratized Approach to Multi-Omic Molecular Profiling Via the LungMATCH Program

P1.01-036 Identifying and Addressing Gaps in Molecular Testing for Patients with Lung Cancer

P1.02-03 The Role of Lung Cancer Advocacy Organizations in Biomarker Testing

Tick-borne encephalitis as a notifiable disease--Status quo and the way forward. Report of the 17th annual meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE)

Abstract P5-06-08: Role of Androgen Receptor in Metastasis and Hormone Resistance of Estrogen Receptor Positive Breast Cancer

Abstract P5-06-01: MTA2 and AR Overexpression in ER-Negative Breast Cancer Cells: Roles in Invasion and Metastasis

Suchergebnisse filtern